Luis Furuya-Kanamori
Luis Furuya-Kanamori
Verified email at
Cited by
Cited by
Co-distribution and co-infection of chikungunya and dengue viruses
L Furuya-Kanamori, S Liang, G Milinovich, RJS Magalhaes, ...
BMC infectious diseases 16 (1), 1-11, 2016
Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications
L Furuya-Kanamori, J Marquess, L Yakob, TV Riley, DL Paterson, ...
BMC infectious diseases 15 (1), 1-11, 2015
Comorbidities, exposure to medications, and the risk of community-acquired Clostridium difficile infection: a systematic review and meta-analysis
L Furuya-Kanamori, JC Stone, J Clark, SJ McKenzie, L Yakob, ...
Cambridge University Press, 2014
A new improved graphical and quantitative method for detecting bias in meta-analysis
L Furuya-Kanamori, JJ Barendregt, SAR Doi
International journal of evidence-based healthcare 16 (4), 195-203, 2018
Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis
L Furuya-Kanamori, KJL Bell, J Clark, P Glasziou, SAR Doi
Journal of Clinical Oncology 34 (30), 3672-3679, 2016
WSES guidelines for management of Clostridium difficile infection in surgical patients
M Sartelli, MA Malangoni, FM Abu-Zidan, EA Griffiths, S Di Bella, ...
World Journal of Emergency Surgery 10 (1), 1-23, 2015
Angry birds, angry children, and angry meta-analysts: A reanalysis
L Furuya-Kanamori, SAR Doi
Perspectives on Psychological Science 11 (3), 408-414, 2016
Upper versus lower gastrointestinal delivery for transplantation of fecal microbiota in recurrent or refractory Clostridium difficile infection
L Furuya-Kanamori, DL Paterson, SK Helms, L Yakob, SJ McKenzie, ...
Journal of clinical gastroenterology 51 (2), 145-150, 2017
2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients
M Sartelli, S Di Bella, LV McFarland, S Khanna, L Furuya-Kanamori, ...
World journal of emergency surgery 14 (1), 1-29, 2019
Heterogeneous and dynamic prevalence of asymptomatic influenza virus infections
L Furuya-Kanamori, M Cox, GJ Milinovich, RJS Magalhaes, IM Mackay, ...
Emerging infectious diseases 22 (6), 1052, 2016
Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model
L Yakob, TV Riley, DL Paterson, J Marquess, RJS Magalhaes, ...
Scientific reports 5 (1), 1-9, 2015
Meta-analysis in evidence-based healthcare: a paradigm shift away from random effects is overdue
L Furuya-Kanamori, L Thalib, JJ Barendregt
International Journal of Evidence-Based Healthcare 15 (4), 152-160, 2017
Clostridium difficile infection seasonality: patterns across hemispheres and continents–A systematic review
L Furuya-Kanamori, SJ McKenzie, L Yakob, J Clark, DL Paterson, ...
PloS one 10 (3), e0120730, 2015
The Effect of Right Ventricular Apical and Nonapical Pacing on the Short‐and Long‐Term Changes in Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of†…
MA Hussain, L Furuya-Kanamori, G Kaye, J Clark
Pacing and Clinical Electrophysiology 38 (9), 1121-1136, 2015
Health Outcomes from Multidrug-Resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis
A Parisi, JA Crump, K Glass, BP Howden, L Furuya-Kanamori, S Vilkins, ...
Foodborne Pathogens and Disease 15 (7), 428-436, 2018
Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012–2014: prospective, repeated cross-sectional study
L Furuya-Kanamori, ACA Clements, NF Foster, CA Huber, S Hong, ...
Clinical Microbiology and Infection 23 (1), 48. e1-48. e7, 2017
A population-based spatio-temporal analysis of Clostridium difficile infection in Queensland, Australia over a 10-year period
L Furuya-Kanamori, J Robson, RJS Magalh„es, L Yakob, SJ McKenzie, ...
Journal of Infection 69 (5), 447-455, 2014
Clostridium difficile Infection and Risk of Colectomy in Patients with Inflammatory Bowel Disease: A Bias-adjusted Meta-analysis
Y Chen, L Furuya-Kanamori, SA Doi, AN Ananthakrishnan, M Kirk
Inflammatory bowel diseases 23 (2), 200-207, 2017
Comparison of Clostridium difficile ribotypes circulating in Australian hospitals and communities
L Furuya-Kanamori, TV Riley, DL Paterson, NF Foster, CA Huber, S Hong, ...
Journal of clinical microbiology 55 (1), 216-225, 2017
Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes?
JC Stone, L Furuya‐Kanamori, JJ Barendregt, SAR Doi
Pharmacoepidemiology and drug safety 24 (3), 223-227, 2015
The system can't perform the operation now. Try again later.
Articles 1–20